Literature DB >> 2337872

Autoantibodies in neoplasia. An unresolved enigma.

M Swissa1, H Amital-Teplizki, N Haim, Y Cohen, Y Shoenfeld.   

Abstract

One hundred sixty-four sera samples of patients with malignant diseases were analyzed for the presence of autoantibodies to ssDNA, dsDNA, poly(I), Poly(G), cardiolipin, histones, RNP, Sm, Ro(SSA), and La (SSB). No distinction could be made between these patients and a comparative group composed of age-adjusted healthy subjects when measuring antibody levels to these autoantigens by the ELISA technique. This finding remained valid after further subgrouping of the patients according to age, sex, and histologic origin of the tumor. The authors conclude that in contrast to the known clinical coexistence of neoplasia in autoimmune states, there is no increased incidence of antinuclear autoantibodies in malignant conditions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2337872     DOI: 10.1002/1097-0142(19900601)65:11<2554::aid-cncr2820651126>3.0.co;2-w

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

Review 1.  Uncovering the hidden potential of intravenous immunoglobulin as an anticancer therapy.

Authors:  Tal Sapir; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

2.  Prevalence of paraneoplastic rheumatic syndromes and their antibody profile among patients with solid tumours.

Authors:  Rita Rugienė; Jolanta Dadonienė; Eduardas Aleknavičius; Renatas Tikuišis; Jörg Distler; Georg Schett; Paulius Venalis; Algirdas Venalis
Journal:  Clin Rheumatol       Date:  2011-01-12       Impact factor: 2.980

Review 3.  Management of childhood arthritis. Part 1: Acute arthritis.

Authors:  P N Malleson
Journal:  Arch Dis Child       Date:  1997-05       Impact factor: 3.791

Review 4.  Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies.

Authors:  M Abu-Shakra; D Buskila; M Ehrenfeld; K Conrad; Y Shoenfeld
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

5.  Antinuclear antibodies as potential markers of lung cancer.

Authors:  F Fernández-Madrid; P J VandeVord; X Yang; R L Karvonen; P M Simpson; M J Kraut; J L Granda; J E Tomkiel
Journal:  Clin Cancer Res       Date:  1999-06       Impact factor: 12.531

6.  Autoimmunity to the M(r) 32,000 subunit of replication protein A in breast cancer.

Authors:  J E Tomkiel; H Alansari; N Tang; J B Virgin; X Yang; P VandeVord; R L Karvonen; J L Granda; M J Kraut; J F Ensley; F Fernández-Madrid
Journal:  Clin Cancer Res       Date:  2002-03       Impact factor: 12.531

7.  Vitiligo- and melanoma-associated hypopigmentation: a similar appearance but a different mechanism.

Authors:  O Merimsky; Y Shoenfeld; G Yecheskel; S Chaitchik; E Azizi; P Fishman
Journal:  Cancer Immunol Immunother       Date:  1994-06       Impact factor: 6.968

8.  Review for the generalist: The antinuclear antibody test in children - When to use it and what to do with a positive titer.

Authors:  Peter N Malleson; Murray J Mackinnon; Michaela Sailer-Hoeck; Charles H Spencer
Journal:  Pediatr Rheumatol Online J       Date:  2010-10-20       Impact factor: 3.054

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.